Formulations

Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More


  • No Image
    Medicamen Biotech Ltd

    Medicamen Biotech Limited is a widely held, globally recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and dome

  • No Image
    Medico Remedies Pvt Ltd

    Medico Remedies Pvt Ltd was incorporated in1994. It is engaged in the manufacture of tablets, capsules, dry syrups formulations at its manufacturing facility located at Palghar,